A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection.
Zhong L, Zhang W, Liu H, Zhang X, Yang Z, Wen Z, Chen L, Chen H, Luo Y, Chen Y, Feng Q, Zeng MS, Zhao Q, Liu L, Krummenacher C, Zeng YX, Chen Y, Xu M, Zhang X.
Zhong L, et al.
Nat Commun. 2024 Jun 21;15(1):5310. doi: 10.1038/s41467-024-49546-w.
Nat Commun. 2024.
PMID: 38906867
Free PMC article.